raltegravir Di des fluoro impurity

Raltegravir di-des-fluoro impurity is a structurally related degradation byproduct arising from the removal of two fluorine atoms at the 5- and 6-positions of the parent naphthyridine core of raltegravir. This defluorination alters the electronic and steric properties of the aromatic system while retaining the cyclopropylmethyl amide side chain. The compound features a fully dehydrogenated bicyclic naphthyridine scaffold with diminished fluorine-mediated hydrophobic interactions compared to the active pharmaceutical ingredient. It serves as a critical HPLC reference standard for quantifying process-related impurities in raltegravir API synthesis.